HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sameer N Goyal Selected Research

Cannabinoids

1/2021β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.
1/2021Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist.
1/2021β-Caryophyllene, a natural bicyclic sesquiterpene attenuates β-adrenergic agonist-induced myocardial injury in a cannabinoid receptor-2 dependent and independent manner.
12/2020Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sameer N Goyal Research Topics

Disease

17Inflammation (Inflammations)
06/2022 - 04/2016
14Myocardial Infarction
01/2024 - 01/2014
10Neoplasms (Cancer)
09/2022 - 01/2016
10Cardiotoxicity
07/2021 - 01/2015
7Myocardial Ischemia (Ischemic Heart Diseases)
11/2020 - 01/2014
5COVID-19
02/2021 - 01/2021
5Infections
02/2021 - 01/2017
5Reperfusion Injury
01/2020 - 01/2016
5Ischemia
09/2018 - 01/2014
4Neuralgia (Stump Neuralgia)
10/2021 - 01/2016
3Edema (Dropsy)
03/2024 - 02/2016
3Necrosis
10/2022 - 05/2017
3Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2017
3Hyperglycemia
05/2017 - 01/2016
2Asthma (Bronchial Asthma)
02/2024 - 09/2022
2Rheumatoid Arthritis
02/2024 - 01/2021
2Nervous System Diseases (Neurological Disorders)
02/2024 - 10/2021
2Neuroinflammatory Diseases
09/2023 - 10/2021
2Ulcerative Colitis
09/2022 - 01/2017
2Arthritis (Polyarthritis)
09/2022 - 01/2021
2Alcoholism (Alcohol Abuse)
10/2021 - 01/2020
2Fibrosis (Cirrhosis)
07/2021 - 01/2021
2Mitochondrial Diseases (Mitochondrial Disease)
07/2021 - 11/2018
2Pain (Aches)
01/2021 - 11/2018
2Dyslipidemias (Dyslipidemia)
01/2021 - 11/2020
2Body Weight (Weight, Body)
01/2016 - 01/2015
1Alzheimer Disease (Alzheimer's Disease)
02/2024
1Parkinsonian Disorders (Parkinsonism)
02/2024
1Psoriasis (Pustulosis Palmaris et Plantaris)
02/2023
1Parkinson Disease (Parkinson's Disease)
12/2022
1Cognitive Dysfunction
09/2022
1Encephalomyelitis (Myeloencephalitis)
09/2022
1Depressive Disorder (Melancholia)
01/2022
1Mood Disorders (Mood Disorder)
01/2022
1Epilepsy (Aura)
10/2021
1Psychotic Disorders (Schizoaffective Disorder)
10/2021
1Neurodevelopmental Disorders
10/2021
1Stroke (Strokes)
10/2021
1Wounds and Injuries (Trauma)
10/2021

Drug/Important Bio-Agent (IBA)

10Isoproterenol (Isoprenaline)FDA LinkGeneric
10/2022 - 01/2015
8AntioxidantsIBA
04/2022 - 01/2016
7CytokinesIBA
02/2024 - 01/2016
5Doxorubicin (Adriamycin)FDA LinkGeneric
07/2021 - 01/2016
4CB2 Cannabinoid ReceptorIBA
01/2024 - 01/2021
4LipidsIBA
04/2022 - 11/2020
4Antiviral Agents (Antivirals)IBA
02/2021 - 01/2021
4CannabinoidsIBA
01/2021 - 12/2020
3CarrageenanIBA
03/2024 - 02/2016
3thymoquinoneIBA
06/2022 - 01/2016
3EnzymesIBA
04/2022 - 01/2020
3InflammasomesIBA
07/2021 - 01/2017
3PhytochemicalsIBA
01/2021 - 01/2014
3kaempferolIBA
01/2020 - 01/2016
3Eplerenone (Inspra)FDA LinkGeneric
09/2018 - 01/2015
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
04/2017 - 01/2014
2Neuroprotective AgentsIBA
02/2024 - 10/2018
2NeuropeptidesIBA
02/2024 - 01/2022
2EndocannabinoidsIBA
09/2023 - 08/2021
2Interleukin-6 (Interleukin 6)IBA
06/2022 - 05/2017
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
04/2022 - 12/2020
21,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA
10/2021 - 01/2021
2SesquiterpenesIBA
07/2021 - 11/2020
2nerolidolIBA
07/2021 - 06/2021
2Free RadicalsIBA
07/2021 - 11/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 06/2018
2alloinIBA
01/2020 - 01/2020
2Disulfiram (Antabuse)FDA Link
01/2020 - 10/2018
2Omeprazole (Prilosec)FDA LinkGeneric
06/2019 - 01/2016
2Receptor for Advanced Glycation End ProductsIBA
05/2017 - 01/2017
2Advanced Glycation End ProductsIBA
05/2017 - 01/2017
2Mitogen-Activated Protein KinasesIBA
05/2017 - 04/2016
2mangiferinIBA
01/2017 - 04/2016
2HesperidinIBA
08/2014 - 01/2014
1Ibuprofen (Motrin)FDA LinkGeneric
03/2024
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2024
1Ointments (Pastes)IBA
02/2023
1entacapone (Comtan)FDA Link
12/2022
1catechol (pyrocatechol)IBA
12/2022
1TransferasesIBA
12/2022
1Dopamine Agonists (Dopamine Agonist)IBA
12/2022
1PhloretinIBA
09/2022
1CurcuminIBA
04/2022
1Glucose (Dextrose)FDA LinkGeneric
04/2022
1GhrelinIBA
01/2022
1Growth Hormone (Somatotropin)IBA
01/2022
1LigandsIBA
10/2021
1AnthracyclinesIBA
07/2021
1Volatile Oils (Essential Oils)IBA
07/2021
1Antineoplastic Agents (Antineoplastics)IBA
07/2021
1Therapeutic UsesIBA
02/2021
1PPAR gammaIBA
02/2021
1serratiopeptidaseIBA
01/2021
1caryophylleneIBA
01/2021
1Immunologic Factors (Immunomodulators)IBA
01/2021
1Serine Proteases (Serine Protease)IBA
01/2021

Therapy/Procedure

3Therapeutics
12/2020 - 01/2016
2Oral Administration
10/2022 - 01/2020
2Drug Therapy (Chemotherapy)
01/2020 - 10/2018
2Ligation
05/2017 - 01/2016
1Immunomodulation
02/2021